Knight Therapeutics (TSE:GUD) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Knight Therapeutics Inc. successfully concluded its Annual General Meeting, with all director nominees from the Management Information Circular being elected with high approval rates. Additionally, Ernst & Young LLP were appointed as external auditors with overwhelming shareholder support, and a resolution to renew unallocated rights under the Omnibus Equity Incentive Plan was approved by a significant majority.
For further insights into TSE:GUD stock, check out TipRanks’ Stock Analysis page.
